Questcor Pharmacueticals (QCOR) Tops Q2 EPS by 6c

Questcor Pharmacueticals (NASDAQ: QCOR) reported Q2 EPS of $0.69, $0.06 better than the analyst estimate of $0.63. Revenue for the quarter came in at $112.5 million versus the consensus estimate of $108.91 million.

For earnings history and earnings-related data on Questcor Pharmacueticals (QCOR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Nortech Systems, Inc. (NSYS) Tops Q2 EPS by 11c
• Epsilon Energy Ltd. (EPSN) Reports Q2 EPS of $0.23